Skip to main content
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: Am J Geriatr Psychiatry. 2008 Dec;16(12):999–1009. doi: 10.1097/JGP.0b013e31818cd3a4

TABLE 2.

Baseline and Post-Treatment Neuropsychological Test Scoresa Within Each Cognitive Domain

Celecoxib (n = 22), Mean (SD)
Placebo (n = 18), Mean (SD)
Domain Test Baseline Post-Treatment Baseline Post-Treatment
Psychomotor speed Trailmaking A 32.4 (12.9) 30.7 (9.7) 29.5 (9.3) 28.3 (9.0)
WAIS-III digit symbol 70.3 (15.7) 69.0 (17.8) 72.1 (17.1) 74.0 (18.4)
Visuospatial functioning WAIS-III block design 37.0 (9.8) 40.4 (7.5) 41.1 (11.5) 41.1 (12.7)
Complex figure, copy 30.4 (4.0) 30.8 (3.3) 31.8 (2.8) 30.6 (2.9)
Executive functioningb Trailmaking B 80.3 (34.1) 78.4 (43.3) 65.6 (22.2) 71.2 (37.5)
Stroop interference 127.2 (30.1) 121.0 (30.5) 122.9 (36.8) 125.4 (46.6)
F.A.S. letter fluency 38.4 (13.6) 40.9 (14.3) 41.9 (17.6) 44.2 (18.7)
Learning Selective reminding, total recall 102.6 (13.5) 103.9 (18.0) 106.9 (20.8) 111.6 (19.0)
Verbal paired associations I 17.6 (7.6) 20.6 (8.0) 19.5 (9.0) 21.5 (8.6)
Benton visual retention 3.9 (1.9) 4.3 (2.0) 3.9 (2.5) 4.7 (3.6)
Delayed recall Selective reminding, delayed recall 7.9 (3.0) 8.3 (2.7) 9.2 (3.6) 9.8 (2.7)
Complex figure, recall 15.8 (6.9) 17.3 (7.7) 17.3 (7.7) 16.8 (7.5)
Verbal paired associations II 6.4 (1.7) 6.6 (2.1) 6.2 (2.3) 7.3 (2.6)
Language/semantic memoryc Boston naming 54.9 (3.5) 55.5 (3.6) 55.9 (4.3) 55.7 (5.5)
Animal naming 21.5 (5.7) 22.5 (4.6) 20.8 (5.0) 19.4 (6.1)
a

Higher scores indicate better cognitive performance except for Trailmaking A and B, Stroop interference, and Benton Visual Retention, wherein lower scores indicate better performance.

b

F[1,30] = 5.06, p = 0.03.

c

F[1,31] = 6.19, p = 0.02.